Earnings calendar/DNTH
Dianthus Therapeutics, Inc. (DNTH)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 4, 2026
Consensus estimate row
EPS target
$-1.02
Street estimate
Revenue target
$400,833
Street estimate
Trailing EPS (avg 4Q)
$-1.04
Beat rate last 4: 25%
Latest EPS YoY
-2.3%
vs 2025-08-07
Latest revenue YoY
+294.3%
How results look so far
Trailing revenue (avg 4Q)
$476,000
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 4, 2026
EPS miss
EPS actual / est
$-0.90 / $-0.85
-6.3%
Revenue actual / est
$761,000 / $297,182
+156.1%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/4/2026upcoming | $-1.02 | Pending | — | $400,833 | Pending | — |
| 8/4/2026 | $-0.85 | $-0.90 | -6.3% | $297,182 | $761,000 | +156.1% |
| 5/11/2026upcoming | $-1.10 | Pending | — | $403,615 | Pending | — |
| 5/5/2026 | $-1.17 | $-0.85 | +27.4% | $403,615 | $463,000 | +14.7% |
| 3/10/2026upcoming | $-0.98 | Pending | — | $448,250 | Pending | — |
| 3/9/2026 | $-0.98 | $-1.43 | -45.9% | $552,231 | $284,000 | -48.6% |
| 11/5/2025 | $-0.86 | $-0.97 | -12.8% | $576,000 | $396,000 | -31.3% |
| 8/7/2025 | $-0.86 | $-0.88 | -2.3% | $858,200 | $193,000 | -77.5% |
| 5/12/2025 | $-0.86 | $-0.82 | +4.7% | $806,900 | $1.2M | +44.1% |
| 3/11/2025 | $-0.85 | $-0.81 | +4.7% | $955,222 | $1.3M | +38.7% |
| 11/7/2024 | $-0.59 | $-0.74 | -25.4% | $741,143 | $2.2M | +193.1% |
| 8/8/2024 | $-0.55 | $-0.51 | +6.5% | $368,857 | $1.9M | +405.1% |
| 5/9/2024 | $-0.43 | $-0.54 | -25.6% | $464,250 | $874,000 | +88.3% |
| 3/21/2024 | $-1.11 | $-0.71 | +36.0% | $548,500 | $457,000 | -16.7% |
| 11/9/2023 | $-0.51 | $-3.78 | -641.2% | $250,000 | $924,000 | +269.6% |
| 8/3/2023 | $-0.80 | $-3.12 | -290.0% | — | $1.0M | — |
| 5/15/2023 | $-6.40 | $-7.52 | -17.5% | — | $476,000 | — |
| 3/30/2023 | $-6.40 | $-7.70 | -20.2% | — | $476,000 | — |
| 12/31/2022 | $-4.10 | $-2.67 | +34.9% | — | $1.2M | — |
| 12/30/2022 | $-4.10 | $-2.67 | +34.9% | — | $1.2M | — |
| 11/3/2022 | $-4.64 | $-4.32 | +6.9% | — | $1.2M | — |
| 9/30/2022 | $-4.64 | $-2.10 | +54.7% | — | $1.2M | — |
| 8/4/2022 | $-5.44 | $-4.64 | +14.7% | — | Pending | — |
| 5/16/2022 | $-5.09 | $-6.24 | -22.6% | — | Pending | — |
| 3/8/2022 | — | $-5.25 | — | — | Pending | — |
| 11/4/2021 | — | $-4.76 | — | — | Pending | — |
| 8/5/2021 | — | $-5.04 | — | — | Pending | — |
| 5/6/2021 | — | $-5.76 | — | — | Pending | — |
| 3/3/2021 | — | $-5.99 | — | — | Pending | — |
| 11/5/2020 | — | $-5.86 | — | — | Pending | — |
| 8/6/2020 | — | $-7.71 | — | — | Pending | — |
| 5/7/2020 | — | $-8.13 | — | — | Pending | — |
| 3/3/2020 | — | $-9.52 | — | — | Pending | — |
| 11/13/2019 | — | $-8.65 | — | — | Pending | — |
| 8/8/2019 | — | $-7.73 | — | — | Pending | — |
| 5/9/2019 | — | $-7.10 | — | — | Pending | — |
| 3/19/2019 | — | $-8.04 | — | — | Pending | — |
| 11/8/2018 | — | $-7.77 | — | — | Pending | — |
| 8/9/2018 | — | $-49.77 | — | — | Pending | — |
| 3/31/2018 | — | $-5.05 | — | — | Pending | — |
| 12/31/2017 | — | $-3.74 | — | — | Pending | — |
| 9/30/2017 | — | $-3.13 | — | — | Pending | — |
| 6/30/2017 | — | $-7.12 | — | — | Pending | — |
| 3/31/2017 | — | $-2.18 | — | — | Pending | — |